Parameters | Number | Hazard ratio (95% CI) | p value |
---|---|---|---|
Age | Â | Â | 0.233 |
   < 50 | 58 | reference |  |
   50-60 | 59 | -- | 0.124 |
   > 60 | 71 | -- | 0.141 |
Stage | Â | Â | 0.831 |
   I | 22 | reference |  |
   II | 145 | -- | 0.852 |
   III-IVA | 41 | -- | 0.686 |
Parametrial score | Â | Â | 0.056 |
   0 | 36 | reference |  |
   1-3 | 103 | -- | 0.749 |
   4-6 | 49 | -- | 0.222 |
Tumor size (cm) | Â | Â | 0.333 |
   ≤ 5.0 | 48 | reference |  |
   > 5.0 | 53 |  | 0.304 |
   unknown | 87 |  | 0.836 |
Positive pelvic node | Â | -- | 0.170 |
Hemoglobin < 12 g/dL | Â | -- | 0.525 |
Smoking | Â | -- | 0.484 |
Field size (< 18 cm) | Â | -- | 0.959 |
Pretreatment CEA level (ng/mL) | Â | Â | 0.005 |
   < 5 | 149 | reference |  |
   5-10 | 16 | 1.007 (0.232-4.365) | 0.993 |
   ≥ 10 | 23 | 4.206 (1.801-9.821) | 0.001 |
Pretreatment SCC-Ag level (ng/mL) | Â | Â | < 0.001 |
   < 10 | 128 | reference |  |
   10-40 | 42 | 2.617 (1.180-5.804) | 0.018 |
   ≥ 40 | 18 | 6.851 (2.722-16.935) | < 0.001 |